GEF completed a major acquisition that nearly quadrupled revenue to $3.6B while simultaneously changing its fiscal year end from October 31 to September 30, creating an 11-month transition year.
The massive 278% revenue increase combined with references to removing Ipackchem acquisition language suggests this major deal has closed, fundamentally transforming GEF's scale and operations. The fiscal year change to align with calendar quarters indicates strategic repositioning, but creates a challenging 11-month reporting period that will complicate year-over-year comparisons and financial analysis.
While revenue exploded 278% to $3.6B from the major acquisition, profitability metrics declined significantly with net income falling 25% and operating cash flow dropping 45%, suggesting integration challenges or unfavorable deal economics. The company took on substantial additional debt ($500M increase) to fund the expansion, while interest expense paradoxically fell 90%, indicating possible debt restructuring. The overall picture shows a company that has dramatically expanded its footprint but is experiencing margin compression and cash flow pressures during the integration process.
Strong top-line growth of 278.3% — accelerating demand or successful expansion into new markets.
Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.
Operating cash flow fell 45.2% — earnings quality concerns; investigate working capital changes and non-cash items.
Net income declined 25.2% — review whether driven by operations, interest costs, or non-recurring items.
Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.
Debt rose 23% — additional borrowing for investment or operations; monitor coverage ratios.
SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.
Receivables grew 13.3% — monitor days sales outstanding for collection efficiency.
Current assets grew 13.2% — improving short-term liquidity or inventory/receivables build.
Asset base grew 11.5% — expansion through organic growth, acquisitions, or capital deployment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →